Novartis hydroxychloroquine production

Apr 20, 2020 · Basel, April 20, 2020 — Novartis has reached an agreement with the US Food and Drug Administration (FDA) to proceed with a Phase III clinical trial with approximately 440 patients to evaluate the use of hydroxychloroquine for the treatment of hospitalized patients with COVID-19 disease. We have been also contributing to research efforts, supporting communities and ensuring stable supply and price of essential medicines

2024-03-28
    Reglas de la raiz cuadrada
  1. Specifically, the production cost for hydroxychloroquine was $0
  2. Credit: amrothman from Pixabay